在急性失代偿性心力衰竭中，以N末端B型利钠肽原（NT-proBNP）为指导的治疗与传统治疗在再入院率或死亡率方面并无差异。 - Suppr | 超能文献

NT-proBNP-guided and conventional therapies did not differ for readmission or mortality in acute decompensated HF.

作者信息

Misra Arunima, Deswal Anita

出版信息

Ann Intern Med. 2018 Aug 21;169(4):JC21. doi: 10.7326/ACPJC-2018-169-4-021.

DOI:10.7326/ACPJC-2018-169-4-021

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

NT-proBNP-guided and conventional therapies did not differ for readmission or mortality in acute decompensated HF.

Ann Intern Med. 2018 Aug 21;169(4):JC21. doi: 10.7326/ACPJC-2018-169-4-021.

2

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.

Am Heart J. 2014 Jul;168(1):30-6. doi: 10.1016/j.ahj.2014.04.008. Epub 2014 Apr 23.

3

Letter by Madias Regarding Article, "NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)".

Circulation. 2018 Oct 23;138(17):1908-1909. doi: 10.1161/CIRCULATIONAHA.118.035797.

4

Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)".

Circulation. 2018 Oct 23;138(17):1910-1911. doi: 10.1161/CIRCULATIONAHA.118.036445.

5

A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.

Heart. 2014 Jan;100(2):115-25. doi: 10.1136/heartjnl-2013-303632. Epub 2013 Oct 31.

6

N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.

J Card Fail. 2017 May;23(5):382-389. doi: 10.1016/j.cardfail.2017.02.001. Epub 2017 Feb 13.

7

Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.

Am J Cardiol. 2011 Apr 15;107(8):1191-5. doi: 10.1016/j.amjcard.2010.12.018. Epub 2011 Feb 4.

8

NT-ProBNP reduction percentage during hospital stay predicts long-term mortality and readmission in heart failure patients.

J Cardiovasc Med (Hagerstown). 2008 Jul;9(7):694-9. doi: 10.2459/JCM.0b013e3282f447ae.

9

Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.

JACC Heart Fail. 2016 Sep;4(9):736-45. doi: 10.1016/j.jchf.2016.05.007. Epub 2016 Jul 6.

10

Prognosis of decompensated heart failure: role of NT-proBNP.

Rev Port Cardiol. 2007 May;26(5):535-45.

引用本文的文献

1

Efficacy of ozonated autohemotherapy for improvement of myocardial injury following traumatic brain injury.

BMC Anesthesiol. 2024 Sep 11;24(1):324. doi: 10.1186/s12871-024-02684-6.